Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Mapstone

Showing results (91-100 of 147) with videos related to

Pageof 15
Sort By:
Medrxiv : the Preprint Server for Health Sciences|August 30, 2024
Amyloid age and tau PET timeline to symptomatic Alzheimer's disease in Down syndromeEmily K Schworer, Matthew D Zammit, Jiebiao Wang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 2, 2020
The AT(N) framework for Alzheimer's disease in adults with Down syndromeMichael S Rafii, Beau M Ances, Nicole Schupf, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 21, 2026
2-aminobutyrate mediates the impact of air pollution on blood biomarkers of Alzheimer's diseaseAnum Saeed, Chris Mckennan, Jane E Clougherty, et al.
Dementia and Geriatric Cognitive Disorders|June 19, 2013
Impact of mild cognitive impairment on health-related quality of life in Parkinson's diseaseWilliam Reginold, Sarah Duff-Canning, Christopher Meaney, et al.
Ageing Research Reviews|April 29, 2021
Omics sciences for systems biology in Alzheimer's disease: State-of-the-art of the evidenceHarald Hampel, Robert Nisticò, Nicholas T Seyfried, et al.
Alzheimer'S Research & Therapy|May 6, 2017
Communicating mild cognitive impairment diagnoses with and without amyloid imagingJoshua D Grill, Liana G Apostolova, Szofia Bullain, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersShorena Janelidze, Lyduine E Collij, Niklas Mattsson-Carlgren, et al.
Ageing Research Reviews|June 21, 2023
Integrative metabolomics science in Alzheimer's disease: Relevance and future perspectivesSimone Lista, Raúl González-Domínguez, Susana López-Ortiz, et al.
Pharmacological Research|February 20, 2018
Precision pharmacology for Alzheimer's diseaseHarald Hampel, Andrea Vergallo, Lisi Flores Aguilar, et al.
Disability and Health Journal|March 8, 2022
Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndromeSigan L Hartley, Victoria Fleming, Brianna Piro-Gambetti, et al.
Pageof 15

Showing results (91-100 of 147) with videos related to

Sort By:
Pageof 15
Medrxiv : the Preprint Server for Health Sciences|August 30, 2024
Amyloid age and tau PET timeline to symptomatic Alzheimer's disease in Down syndromeEmily K Schworer, Matthew D Zammit, Jiebiao Wang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 2, 2020
The AT(N) framework for Alzheimer's disease in adults with Down syndromeMichael S Rafii, Beau M Ances, Nicole Schupf, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 21, 2026
2-aminobutyrate mediates the impact of air pollution on blood biomarkers of Alzheimer's diseaseAnum Saeed, Chris Mckennan, Jane E Clougherty, et al.
Dementia and Geriatric Cognitive Disorders|June 19, 2013
Impact of mild cognitive impairment on health-related quality of life in Parkinson's diseaseWilliam Reginold, Sarah Duff-Canning, Christopher Meaney, et al.
Ageing Research Reviews|April 29, 2021
Omics sciences for systems biology in Alzheimer's disease: State-of-the-art of the evidenceHarald Hampel, Robert Nisticò, Nicholas T Seyfried, et al.
Alzheimer'S Research & Therapy|May 6, 2017
Communicating mild cognitive impairment diagnoses with and without amyloid imagingJoshua D Grill, Liana G Apostolova, Szofia Bullain, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersShorena Janelidze, Lyduine E Collij, Niklas Mattsson-Carlgren, et al.
Ageing Research Reviews|June 21, 2023
Integrative metabolomics science in Alzheimer's disease: Relevance and future perspectivesSimone Lista, Raúl González-Domínguez, Susana López-Ortiz, et al.
Pharmacological Research|February 20, 2018
Precision pharmacology for Alzheimer's diseaseHarald Hampel, Andrea Vergallo, Lisi Flores Aguilar, et al.
Disability and Health Journal|March 8, 2022
Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndromeSigan L Hartley, Victoria Fleming, Brianna Piro-Gambetti, et al.
Pageof 15